Evidence map›Paper›PMID 36834643›Full record

ArticleInternational journal of molecular sciences2023

Mass Spectrometry Analysis of Globotriaosylsphingosine and Its Analogues in Dried Blood Spots.

Michel Boutin, Pamela Lavoie, Margot Beaudon, Georges Kabala Ntumba, Daniel G Bichet, Bruno Maranda, Christiane Auray-Blais

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Prevalence of Fabry Disease in Patients on Dialysis in France.International journal of molecular sciences · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michel BoutinDivision of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de Recherche-CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0001-6289-1839
Pamela LavoieDivision of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de Recherche-CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Margot BeaudonInstitut de Pharmacologie, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Georges Kabala NtumbaDivision of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de Recherche-CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Daniel G BichetResearch Center, Hôpital du Sacré-Coeur de Montreal, University of Montreal and Nephrology Service, Montreal, QC H4J 1C5, Canada.
Bruno MarandaDivision of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de Recherche-CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Christiane Auray-BlaisDivision of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de Recherche-CIUSSS de l'Estrie-CHUS, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Université de Sherbrooke · CAHôpital du Sacré-Cœur de Montréal · CA

Funding

Funds from C. Auray-Blais NoneSanofi Genzyme None
6 · The paper itself

Abstract

Fabry disease (FD) is an X-linked lysosomal storage disorder where impaired α-galactosidase A enzyme activity leads to the intracellular accumulation of undegraded glycosphingolipids, including globotriaosylsphingosine (lyso-Gb

Indexed as

Fabry DiseaseGlycolipidsalpha-GalactosidaseBiomarkersHumansSphingolipidsTandem Mass Spectrometryalpha-GalactosidaseBiomarkersGlycolipidsSphingolipidsbiomarkersCapitainer®Bdried blood spotsFabry diseaseglobotriaosylsphingosinelyso-Gb3 analoguesmass spectrometry

Identifiers

PMID36834643
PMCPMC9966246
OpenAlexW4319442323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.